Vectura Group plc

Tobacco product giant Philip Morris International Inc. trims its life sciences industry footprint to developing and commercializing consumer health and wellness oral formulations and inhaled Rx drugs

Inhalation specialist Vectura is set to fall into the ownership of Molex’s pharma unit Phillips Medisize, for less than a third of the £1.1bn ($1.45bn) its current owner, the tobacco giant Philip Mo

Tobacco product giant Philip Morris International Inc. trims its life sciences industry footprint to developing and commercializing consumer health and wellness oral formulations and inhaled Rx drugs

Kinaset Therapeutics, Inc. is on a mission to create a convenient, inhaled treatment for severe asthma for use across the spectrum of disease phenotypes, including the insufficiently addressed non-eo